1. Gail Farfel

    0 Comments Leave a Comment

    1-2 of 2
    1. Mentioned In 2 Articles

    2. DURECT Appoints Two New Board Members

      DURECT Appoints Two New Board Members
      CUPERTINO, Calif., April 25, 2019 /PRNewswire/ -- DURECT Corporation (DRRX) announced today the appointment of two new members to its board of directors. Dr. Gail M. Farfel, Executive Vice President and Chief Development Officer of Zogenix, Inc., and Judith J. Robertson, most recently Chief Commercial Officer of Aerie Pharmaceuticals, bring to DURECT extensive product development, regulatory and commercialization experience...
      Read Full Article
    3. 1-2 of 2
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content